{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["ADMET", "DFT", "MD simulations", "SARS-CoV-2", "docking", "main protease", "pharmacophoric", "structural similarity"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "35955547", "DateCompleted": {"Year": "2022", "Month": "08", "Day": "15"}, "DateRevised": {"Year": "2022", "Month": "12", "Day": "07"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "07", "Day": "29"}], "Language": ["eng"], "ELocationID": ["8407", "10.3390/ijms23158407"], "Journal": {"ISSN": "1422-0067", "JournalIssue": {"Volume": "23", "Issue": "15", "PubDate": {"Year": "2022", "Month": "Jul", "Day": "29"}}, "Title": "International journal of molecular sciences", "ISOAbbreviation": "Int J Mol Sci"}, "ArticleTitle": "A Multistage In Silico Study of Natural Potential Inhibitors Targeting SARS-CoV-2 Main Protease.", "Abstract": {"AbstractText": ["Among a group of 310 natural antiviral natural metabolites, our team identified three compounds as the most potent natural inhibitors against the SARS-CoV-2 main protease (PDB ID: 5R84), M<sup>pro</sup>. The identified compounds are sattazolin and caprolactin A and B. A validated multistage in silico study was conducted using several techniques. First, the molecular structures of the selected metabolites were compared with that of <b>GWS</b>, the co-crystallized ligand of M<sup>pro</sup>, in a structural similarity study. The aim of this study was to determine the thirty most similar metabolites (10%) that may bind to the M<sup>pro</sup> similar to <b>GWS</b>. Then, molecular docking against M<sup>pro</sup> and pharmacophore studies led to the choice of five metabolites that exhibited good binding modes against the M<sup>pro</sup> and good fit values against the generated pharmacophore model. Among them, three metabolites were chosen according to ADMET studies. The most promising M<sup>pro</sup> inhibitor was determined by toxicity and DFT studies to be caprolactin A (<b>292</b>). Finally, molecular dynamics (MD) simulation studies were performed for caprolactin A to confirm the obtained results and understand the thermodynamic characteristics of the binding. It is hoped that the accomplished results could represent a positive step in the battle against COVID-19 through further in vitro and in vivo studies on the selected compounds."]}, "AuthorList": [{"Identifier": ["0000-0002-2546-8035"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Sciences, College of Pharmacy, AlMaarefa University, Riyadh 13713, Saudi Arabia."}], "LastName": "Elkaeed", "ForeName": "Eslam B", "Initials": "EB"}, {"Identifier": ["0000-0002-6955-2263"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pharmaceutical Medicinal Chemistry & Drug Design Department, Faculty of Pharmacy (Boys), Al-Azhar University, Cairo 11884, Egypt."}], "LastName": "Eissa", "ForeName": "Ibrahim H", "Initials": "IH"}, {"Identifier": ["0000-0003-0893-6703"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pharmaceutical Medicinal Chemistry & Drug Design Department, Faculty of Pharmacy (Boys), Al-Azhar University, Cairo 11884, Egypt."}], "LastName": "Elkady", "ForeName": "Hazem", "Initials": "H"}, {"Identifier": ["0000-0003-4085-0942"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Faculty of Pharmacy (Boys), Al-Azhar University, Cairo 11884, Egypt."}], "LastName": "Abdelalim", "ForeName": "Ahmed", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Chemistry, University of Jordan, Amman 11942, Jordan."}], "LastName": "Alqaisi", "ForeName": "Ahmad M", "Initials": "AM"}, {"Identifier": ["0000-0003-4497-5013"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Sciences, College of Pharmacy, Princess Nourah bint Abdulrahman University, P.O. Box 84428, Riyadh 11671, Saudi Arabia."}], "LastName": "Alsfouk", "ForeName": "Aisha A", "Initials": "AA"}, {"Identifier": ["0000-0003-4270-616X"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pharmaceutical Medicinal Chemistry & Drug Design Department, Faculty of Pharmacy (Boys), Al-Azhar University, Cairo 11884, Egypt."}], "LastName": "Elwan", "ForeName": "Alaa", "Initials": "A"}, {"Identifier": ["0000-0001-8566-1980"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pharmacognosy and Medicinal Plants Department, Faculty of Pharmacy (Boys), Al-Azhar University, Cairo 11884, Egypt."}, {"Identifier": [], "Affiliation": "Biopharmaceutical Products Research Department, Genetic Engineering and Biotechnology Research Institute, City of Scientific Research and Technological Applications (SRTA-City), Alexandria 21934, Egypt."}], "LastName": "Metwaly", "ForeName": "Ahmed M", "Initials": "AM"}], "GrantList": [{"GrantID": "PNURSP2022R116", "Agency": "Princess Nourah bint Abdulrahman University", "Country": ""}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Int J Mol Sci", "NlmUniqueID": "101092791", "ISSNLinking": "1422-0067"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antiviral Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Protease Inhibitors"}, {"RegistryNumber": "0", "NameOfSubstance": "Viral Nonstructural Proteins"}, {"RegistryNumber": "EC 3.4.22.-", "NameOfSubstance": "3C-like proteinase, SARS-CoV-2"}, {"RegistryNumber": "EC 3.4.22.-", "NameOfSubstance": "Cysteine Endopeptidases"}, {"RegistryNumber": "EC 3.4.22.28", "NameOfSubstance": "Coronavirus 3C Proteases"}], "MeshHeadingList": [{"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Antiviral Agents"}, {"QualifierName": [], "DescriptorName": "Coronavirus 3C Proteases"}, {"QualifierName": ["metabolism"], "DescriptorName": "Cysteine Endopeptidases"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Molecular Docking Simulation"}, {"QualifierName": [], "DescriptorName": "Molecular Dynamics Simulation"}, {"QualifierName": ["chemistry"], "DescriptorName": "Protease Inhibitors"}, {"QualifierName": [], "DescriptorName": "SARS-CoV-2"}, {"QualifierName": ["metabolism"], "DescriptorName": "Viral Nonstructural Proteins"}, {"QualifierName": [], "DescriptorName": "COVID-19 Drug Treatment"}], "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "WHO  WHO Coronavirus (COVID-19) Dashboard.  [(accessed on 19 January 2022)].  Available online:  https://covid19.who.int/"}, {"Citation": "Zhong N., Zheng B., Li Y., Poon L., Xie Z., Chan K., Li P., Tan S., Chang Q., Xie J. Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, People\u2019s Republic of China, in February, 2003. Lancet. 2003;362:1353\u20131358. doi: 10.1016/S0140-6736(03)14630-2.", "ArticleIdList": ["10.1016/S0140-6736(03)14630-2", "PMC7112415", "14585636"]}, {"Citation": "De Groot R.J., Baker S.C., Baric R.S., Brown C.S., Drosten C., Enjuanes L., Fouchier R.A., Galiano M., Gorbalenya A.E., Memish Z.A. Commentary: Middle east respiratory syndrome coronavirus (mers-cov): Announcement of the coronavirus study group. J. Virol. 2013;87:7790\u20137792. doi: 10.1128/JVI.01244-13.", "ArticleIdList": ["10.1128/JVI.01244-13", "PMC3700179", "23678167"]}, {"Citation": "Macalino S.J.Y., Gosu V., Hong S., Choi S. Role of computer-aided drug design in modern drug discovery. Arch. Pharmacol. Res. 2015;38:1686\u20131701. doi: 10.1007/s12272-015-0640-5.", "ArticleIdList": ["10.1007/s12272-015-0640-5", "26208641"]}, {"Citation": "Zhang S. Computer-aided drug discovery and development. Drug Des. Discov. 2011;716:23\u201338.", "ArticleIdList": ["21318898"]}, {"Citation": "El-Adl K., Sakr H.M., Yousef R.G., Mehany A.B., Metwaly A.M., Elhendawy M.A., Radwan M.M., ElSohly M.A., Abulkhair H.S., Eissa I.H. Discovery of new quinoxaline-2 (1H)-one-based anticancer agents targeting VEGFR-2 as inhibitors: Design, synthesis, and anti-proliferative evaluation. Bioorganic Chem. 2021;114:105105. doi: 10.1016/j.bioorg.2021.105105.", "ArticleIdList": ["10.1016/j.bioorg.2021.105105", "34175720"]}, {"Citation": "El-Adl K., El-Helby A.-G.A., Ayyad R.R., Mahdy H.A., Khalifa M.M., Elnagar H.A., Mehany A.B., Metwaly A.M., Elhendawy M.A., Radwan M.M. Design, synthesis, and anti-proliferative evaluation of new quinazolin-4 (3H)-ones as potential VEGFR-2 inhibitors. Bioorganic Med. Chem. 2021;29:115872. doi: 10.1016/j.bmc.2020.115872.", "ArticleIdList": ["10.1016/j.bmc.2020.115872", "33214036"]}, {"Citation": "Eissa I.H., El-Helby A.-G.A., Mahdy H.A., Khalifa M.M., Elnagar H.A., Mehany A.B., Metwaly A.M., Elhendawy M.A., Radwan M.M., ElSohly M.A. Discovery of new quinazolin-4(3H)-ones as VEGFR-2 inhibitors: Design, synthesis, and anti-proliferative evaluation. Bioorganic Chem. 2020;105:104380. doi: 10.1016/j.bioorg.2020.104380.", "ArticleIdList": ["10.1016/j.bioorg.2020.104380", "33128967"]}, {"Citation": "Abbass E.M., Khalil A.K., Mohamed M.M., Eissa I.H., El-Naggar A.M. Design, efficient synthesis, docking studies, and anticancer evaluation of new quinoxalines as potential intercalative Topo II inhibitors and apoptosis inducers. Bioorganic Chem. 2020;104:104255. doi: 10.1016/j.bioorg.2020.104255.", "ArticleIdList": ["10.1016/j.bioorg.2020.104255", "32927130"]}, {"Citation": "Sliwoski G., Kothiwale S., Meiler J., Lowe E.W. Computational methods in drug discovery. Pharmacol. Rev. 2014;66:334\u2013395. doi: 10.1124/pr.112.007336.", "ArticleIdList": ["10.1124/pr.112.007336", "PMC3880464", "24381236"]}, {"Citation": "Metwaly A.M., Ghoneim M.M., Eissa I.H., Elsehemy I.A., Mostafa A.E., Hegazy M.M., Afifi W.M., Dou D. Traditional ancient Egyptian medicine: A review. Saudi J. Biol. Sci. 2021;28:5823\u20135832. doi: 10.1016/j.sjbs.2021.06.044.", "ArticleIdList": ["10.1016/j.sjbs.2021.06.044", "PMC8459052", "34588897"]}, {"Citation": "Han X., Yang Y., Metwaly A.M., Xue Y., Shi Y., Dou D. The Chinese herbal formulae (Yitangkang) exerts an antidiabetic effect through the regulation of substance metabolism and energy metabolism in type 2 diabetic rats. J. Ethnopharmacol. 2019;239:111942. doi: 10.1016/j.jep.2019.111942.", "ArticleIdList": ["10.1016/j.jep.2019.111942", "31075380"]}, {"Citation": "Metwaly A.M., Lianlian Z., Luqi H., Deqiang D. Black ginseng and its saponins: Preparation, phytochemistry and pharmacological effects. Molecules. 2019;24:1856. doi: 10.3390/molecules24101856.", "ArticleIdList": ["10.3390/molecules24101856", "PMC6572638", "31091790"]}, {"Citation": "Wang Y.-M., Ran X.-K., Riaz M., Yu M., Cai Q., Dou D.-Q., Metwaly A.M., Kang T.-G., Cai D.-C. Chemical constituents of stems and leaves of Tagetespatula L. and its fingerprint. Molecules. 2019;24:3911. doi: 10.3390/molecules24213911.", "ArticleIdList": ["10.3390/molecules24213911", "PMC6864839", "31671631"]}, {"Citation": "Metwaly A. Comparative biological evaluation of four endophytic fungi isolated from nigella sativa seeds. Al-Azhar J. Pharm. Sci. 2019;59:123\u2013136. doi: 10.21608/ajps.2019.64111.", "ArticleIdList": ["10.21608/ajps.2019.64111"]}, {"Citation": "Metwaly A.M., Wanas A.S., Radwan M.M., Ross S.A., ElSohly M.A. New \u03b1-Pyrone derivatives from the endophytic fungus Embellisia sp. Med. Chem. Res. 2017;26:1796\u20131800. doi: 10.1007/s00044-017-1889-7.", "ArticleIdList": ["10.1007/s00044-017-1889-7"]}, {"Citation": "Yassin A.M., El-Deeb N.M., Metwaly A.M., El Fawal G.F., Radwan M.M., Hafez E.E. Induction of apoptosis in human cancer cells through extrinsic and intrinsic pathways by Balanites aegyptiaca furostanol saponins and saponin-coated silvernanoparticles. Appl. Biochem. Biotechnol. 2017;182:1675\u20131693. doi: 10.1007/s12010-017-2426-3.", "ArticleIdList": ["10.1007/s12010-017-2426-3", "28236195"]}, {"Citation": "Sharaf M.H., El-Sherbiny G.M., Moghannem S.A., Abdelmonem M., Elsehemy I.A., Metwaly A.M., Kalaba M.H. New combination approaches to combat methicillin-resistant Staphylococcus aureus (MRSA) Sci. Rep. 2021;11:4240. doi: 10.1038/s41598-021-82550-4.", "ArticleIdList": ["10.1038/s41598-021-82550-4", "PMC7896049", "33608582"]}, {"Citation": "Metwaly A.M., Ghoneim M.M., Musa A. Two new antileishmanial diketopiperazine alkaloids from the endophytic fungus Trichosporum sp. Derpharmachemica. 2015;7:322\u2013327."}, {"Citation": "Metwaly A.M., Fronczek F.R., Ma G., Kadry H.A., Atef A., Mohammad A.-E.I., Cutler S.J., Ross S.A. Antileukemic \u03b1-pyrone derivatives from the endophytic fungus Alternaria phragmospora. Tetrahedron Lett. 2014;55:3478\u20133481. doi: 10.1016/j.tetlet.2014.04.085.", "ArticleIdList": ["10.1016/j.tetlet.2014.04.085", "PMC5047437", "27708462"]}, {"Citation": "Suleimen Y.M., Metwaly A.M., Mostafa A.E., Elkaeed E.B., Liu H.-W., Basnet B.B., Suleimen R.N., Ishmuratova M.Y., Turdybekov K.M., Van Hecke K. Isolation, Crystal Structure, and In Silico Aromatase Inhibition Activity of Ergosta-5,22-dien-3\u03b2-ol from the Fungus Gyromitra esculenta. J. Chem. 2021;2021:5529786. doi: 10.1155/2021/5529786.", "ArticleIdList": ["10.1155/2021/5529786"]}, {"Citation": "Metwaly A.M., Kadry H.A., Atef A., Mohammad A.-E.I., Ma G., Cutler S.J., Ross S.A. Nigrosphaerin A a new isochromene derivative from the endophytic fungus Nigrospora sphaerica. Phytochem. Lett. 2014;7:1\u20135. doi: 10.1016/j.phytol.2013.09.001.", "ArticleIdList": ["10.1016/j.phytol.2013.09.001", "PMC5047436", "27708743"]}, {"Citation": "Ghoneim M.M., Afifi W.M., Ibrahim M., Elagawany M., Khayat M.T., Aboutaleb M.H., Metwaly A.M. Biological evaluation and molecular docking study of metabolites from Salvadora Persica L. Growing in Egypt. Pharmacogn. Mag. 2019;15:232."}, {"Citation": "Liu L., Luo S., Yu M., Metwaly A.M., Ran X., Ma C., Dou D., Cai D. Chemical Constituents of Tagetes patula and Their Neuroprotecting Action. Nat. Prod. Commun. 2020;15:1934578X20974507."}, {"Citation": "Jalmakhanbetova R.I., Suleimen Y.M., Oyama M., Elkaeed E.B., Eissa I., Suleimen R.N., Metwaly A.M., Ishmuratova M.Y. Isolation and In Silico Anti-COVID-19 Main Protease (Mpro) Activities of Flavonoids and a Sesquiterpene Lactone from Artemisia sublessingiana. J. Chem. 2021;2021:5547013. doi: 10.1155/2021/5547013.", "ArticleIdList": ["10.1155/2021/5547013"]}, {"Citation": "Zhanzhaxina A., Suleimen Y., Metwaly A.M., Eissa I.H., Elkaeed E.B., Suleimen R., Ishmuratova M., Akatan K., Luyten W. In Vitro and In Silico Cytotoxic and Antibacterial Activities of a Diterpene from Cousinia alata Schrenk. J. Chem. 2021;2021:5542455. doi: 10.1155/2021/5542455.", "ArticleIdList": ["10.1155/2021/5542455"]}, {"Citation": "Imieje V.O., Zaki A.A., Metwaly A.M., Mostafa A.E., Elkaeed E.B., Falodun A. Comprehensive In Silico Screening of the Antiviral Potentialities of a New Humulene Glucoside from Asteriscus hierochunticus against SARS-CoV-2. J. Chem. 2021;2021:5541876. doi: 10.1155/2021/5541876.", "ArticleIdList": ["10.1155/2021/5541876"]}, {"Citation": "Imieje V.O., Zaki A.A., Metwaly A.M., Eissa I.H., Elkaeed E.B., Ali Z., Khan I.A., Falodun A. Antileishmanial Derivatives of Humulene from Asteriscus hierochunticus with in silico Tubulin Inhibition Potential. Rec. Nat. Prod. 2021;16:150\u2013171."}, {"Citation": "Jalmakhanbetova R., Elkaeed E.B., Eissa I.H., Metwaly A.M., Suleimen Y.M. Synthesis and Molecular Docking of Some Grossgemin Amino Derivatives as Tubulin Inhibitors Targeting Colchicine Binding Site. J. Chem. 2021;2021:5586515. doi: 10.1155/2021/5586515.", "ArticleIdList": ["10.1155/2021/5586515"]}, {"Citation": "Agbowuro A.A., Huston W.M., Gamble A.B., Tyndall J.D. Proteases and protease inhibitors in infectious diseases. Med. Res. Rev. 2018;38:1295\u20131331. doi: 10.1002/med.21475.", "ArticleIdList": ["10.1002/med.21475", "29149530"]}, {"Citation": "Du Q.-S., Wang S.-Q., Zhu Y., Wei D.-Q., Guo H., Sirois S., Chou K.-C. Polyprotein cleavage mechanism of SARS CoV Mpro and chemical modification of the octapeptide. Peptides. 2004;25:1857\u20131864. doi: 10.1016/j.peptides.2004.06.018.", "ArticleIdList": ["10.1016/j.peptides.2004.06.018", "PMC7115412", "15501516"]}, {"Citation": "Hegyi A., Ziebuhr J. Conservation of substrate specificities among coronavirus main proteases. J. Gen. Virol. 2002;83:595\u2013599. doi: 10.1099/0022-1317-83-3-595.", "ArticleIdList": ["10.1099/0022-1317-83-3-595", "11842254"]}, {"Citation": "Liang P.-H. Characterization and inhibition of SARS-coronavirus main protease. Curr. Top. Med. Chem. 2006;6:361\u2013376. doi: 10.2174/156802606776287090.", "ArticleIdList": ["10.2174/156802606776287090", "16611148"]}, {"Citation": "Ullrich S., Nitsche C. The SARS-CoV-2 main protease as drug target. Bioorganic Med. Chem. Lett. 2020;30:127377. doi: 10.1016/j.bmcl.2020.127377.", "ArticleIdList": ["10.1016/j.bmcl.2020.127377", "PMC7331567", "32738988"]}, {"Citation": "Kneller D.W., Phillips G., O\u2019Neill H.M., Jedrzejczak R., Stols L., Langan P., Joachimiak A., Coates L., Kovalevsky A. Structural plasticity of SARS-CoV-2 3CL M pro active site cavity revealed by room temperature X-ray crystallography. Nat. Commun. 2020;11:3202. doi: 10.1038/s41467-020-16954-7.", "ArticleIdList": ["10.1038/s41467-020-16954-7", "PMC7314768", "32581217"]}, {"Citation": "Douangamath A., Fearon D., Gehrtz P., Krojer T., Lukacik P., Owen C.D., Resnick E., Strain-Damerell C., Aimon A., \u00c1br\u00e1nyi-Balogh P. Crystallographic and electrophilic fragment screening of the SARS-CoV-2 main protease. Nat. Commun. 2020;11:5047. doi: 10.1038/s41467-020-18709-w.", "ArticleIdList": ["10.1038/s41467-020-18709-w", "PMC7542442", "33028810"]}, {"Citation": "Mengist H.M., Dilnessa T., Jin T. Structural basis of potential inhibitors targeting SARS-CoV-2 main protease. Front. Chem. 2021;9:622898. doi: 10.3389/fchem.2021.622898.", "ArticleIdList": ["10.3389/fchem.2021.622898", "PMC8056153", "33889562"]}, {"Citation": "Dong S., Sun J., Mao Z., Wang L., Lu Y.L., Li J. A guideline for homology modeling of the proteins from newly discovered betacoronavirus, 2019 novel coronavirus (2019-nCoV) J. Med. Virol. 2020;92:1542\u20131548. doi: 10.1002/jmv.25768.", "ArticleIdList": ["10.1002/jmv.25768", "PMC7228330", "32181901"]}, {"Citation": "Pundir H., Joshi T., Joshi T., Sharma P., Mathpal S., Chandra S., Tamta S. Using Chou\u2019s 5-steps rule to study pharmacophore-based virtual screening of SARS-CoV-2 Mpro inhibitors. Mol. Divers. 2021;25:1731\u20131744. doi: 10.1007/s11030-020-10148-5.", "ArticleIdList": ["10.1007/s11030-020-10148-5", "PMC7573527", "33079314"]}, {"Citation": "Beirami A.D., Hatamabadi D., Iranpanah S., Rezaei M., Ziai S.A. In Silico Identification of Potentially Effective Herbal Inhibitors of SARS-Cov-2 Main Protease by Virtual Screening Method. Sch. Med. Stud. J. 2020;2:2\u20136."}, {"Citation": "Ling R., Dai Y., Huang B., Huang W., Yu J., Lu X., Jiang Y. In silico design of antiviral peptides targeting the spike protein of SARS-CoV-2. Peptides. 2020;130:170328. doi: 10.1016/j.peptides.2020.170328.", "ArticleIdList": ["10.1016/j.peptides.2020.170328", "PMC7198429", "32380200"]}, {"Citation": "Doytchinova I.A., Flower D.R. VaxiJen: A server for prediction of protective antigens, tumour antigens and subunit vaccines. BMC Bioinform. 2007;8:4. doi: 10.1186/1471-2105-8-4.", "ArticleIdList": ["10.1186/1471-2105-8-4", "PMC1780059", "17207271"]}, {"Citation": "Ng Y.L., Salim C.K., Chu J.J.H. Drug repurposing for COVID-19: Approaches, challenges and promising candidates. Pharmacol. Ther. 2021;228:107930. doi: 10.1016/j.pharmthera.2021.107930.", "ArticleIdList": ["10.1016/j.pharmthera.2021.107930", "PMC8220862", "34174275"]}, {"Citation": "Alesawy M.S., Abdallah A.E., Taghour M.S., Elkaeed E.B., H Eissa I., Metwaly A.M. In Silico Studies of Some Isoflavonoids as Potential Candidates against COVID-19 Targeting Human ACE2 (hACE2) and Viral Main Protease (Mpro) Molecules. 2021;26:2806. doi: 10.3390/molecules26092806.", "ArticleIdList": ["10.3390/molecules26092806", "PMC8126168", "34068579"]}, {"Citation": "El-Demerdash A., Metwaly A.M., Hassan A., El-Aziz A., Mohamed T., Elkaeed E.B., Eissa I.H., Arafa R.K., Stockand J.D. Comprehensive virtual screening of the antiviral potentialities of marine polycyclic guanidine alkaloids against SARS-CoV-2 (COVID-19) Biomolecules. 2021;11:460. doi: 10.3390/biom11030460.", "ArticleIdList": ["10.3390/biom11030460", "PMC8003478", "33808721"]}, {"Citation": "Metwaly A.M., Elkaeed E.B., Alsfouk B.A., Saleh A.M., Mostafa A.E., Eissa I.H. The Computational Preventive Potential of the Rare Flavonoid, Patuletin, Isolated from Tagetes patula, against SARS-CoV-2. Plants. 2022;11:1886. doi: 10.3390/plants11141886.", "ArticleIdList": ["10.3390/plants11141886", "PMC9323967", "35890520"]}, {"Citation": "Suleimen Y.M., Jose R.A., Suleimen R.N., Arenz C., Ishmuratova M., Toppet S., Dehaen W., Alsfouk A.A., Elkaeed E.B., Eissa I.H. Isolation and In Silico Anti-SARS-CoV-2 Papain-Like Protease Potentialities of Two Rare 2-Phenoxychromone Derivatives from Artemisia spp. Molecules. 2022;27:1216. doi: 10.3390/molecules27041216.", "ArticleIdList": ["10.3390/molecules27041216", "PMC8879996", "35209006"]}, {"Citation": "Eissa I.H., Khalifa M.M., Elkaeed E.B., Hafez E.E., Alsfouk A.A., Metwaly A.M. In Silico Exploration of Potential Natural Inhibitors against SARS-Cov-2 nsp10. Molecules. 2021;26:6151. doi: 10.3390/molecules26206151.", "ArticleIdList": ["10.3390/molecules26206151", "PMC8539059", "34684735"]}, {"Citation": "Alesawy M.S., Elkaeed E.B., Alsfouk A.A., Metwaly A.M., Eissa I. In Silico Screening of Semi-Synthesized Compounds as Potential Inhibitors for SARS-CoV-2 Papain-Like Protease: Pharmacophoric Features, Molecular Docking, ADMET, Toxicity and DFT Studies. Molecules. 2021;26:6593. doi: 10.3390/molecules26216593.", "ArticleIdList": ["10.3390/molecules26216593", "PMC8588135", "34771004"]}, {"Citation": "El Sayed K.A. Natural products as antiviral agents. Stud. Nat. Prod. Chem. 2000;24:473\u2013572."}, {"Citation": "Gogineni V., Schinazi R.F., Hamann M.T. Role of marine natural products in the genesis of antiviral agents. Chem. Rev. 2015;115:9655\u20139706. doi: 10.1021/cr4006318.", "ArticleIdList": ["10.1021/cr4006318", "PMC4883660", "26317854"]}, {"Citation": "Top\u00e7u G., \u015eenol H., Alim Toraman G., Altan V. Natural alkaloids as potential anti-coronavirus compounds. Bezmialem Sci. 2020;8:131\u2013139. doi: 10.14235/bas.galenos.2020.5035.", "ArticleIdList": ["10.14235/bas.galenos.2020.5035"]}, {"Citation": "Zakaryan H., Arabyan E., Oo A., Zandi K. Flavonoids: Promising natural compounds against viral infections. Arch. Virol. 2017;162:2539\u20132551. doi: 10.1007/s00705-017-3417-y.", "ArticleIdList": ["10.1007/s00705-017-3417-y", "PMC7087220", "28547385"]}, {"Citation": "Vilas Boas L.C.P., Campos M.L., Berlanda R.L.A., de Carvalho Neves N., Franco O.L.J.C., Sciences M.L. Antiviral peptides as promising therapeutic drugs. Cell. Mol. Life Sci. 2019;76:3525\u20133542. doi: 10.1007/s00018-019-03138-w.", "ArticleIdList": ["10.1007/s00018-019-03138-w", "PMC7079787", "31101936"]}, {"Citation": "Klebe G., Abraham U., Mietzner T. Molecular similarity indices in a comparative analysis (CoMSIA) of drug molecules to correlate and predict their biological activity. J. Med. Chem. 1994;37:4130\u20134146. doi: 10.1021/jm00050a010.", "ArticleIdList": ["10.1021/jm00050a010", "7990113"]}, {"Citation": "Braga R.C., Andrade C.H. Assessing the performance of 3D pharmacophore models in virtual screening: How good are they? Curr. Top. Med. Chem. 2013;13:1127\u20131138. doi: 10.2174/1568026611313090010.", "ArticleIdList": ["10.2174/1568026611313090010", "23651486"]}, {"Citation": "Muchtaridi M., Syahidah H.N., Subarnas A., Yusuf M., Bryant S.D., Langer T. Molecular docking and 3D-pharmacophore modeling to study the interactions of chalcone derivatives with estrogen receptor alpha. Pharmaceuticals. 2017;10:81. doi: 10.3390/ph10040081.", "ArticleIdList": ["10.3390/ph10040081", "PMC5748638", "29035298"]}, {"Citation": "Kutlushina A., Khakimova A., Madzhidov T., Polishchuk P. Ligand-based pharmacophore modeling using novel 3D pharmacophore signatures. Molecules. 2018;23:3094. doi: 10.3390/molecules23123094.", "ArticleIdList": ["10.3390/molecules23123094", "PMC6321403", "30486389"]}, {"Citation": "Lima I.R., Vieira J., Silva I.B., Leite R., Maia M., Leite S.P. Indican from A\u00f1il (Indigofera suffruticosa Miller) as an herbal protective agent to the liver. Anal. Quant. Cytopathol. Histopathol. 2014;36:41\u201345.", "ArticleIdList": ["24902370"]}, {"Citation": "Zou P., Koh H.L. Determination of indican, isatin, indirubin and indigotin in Isatis indigotica by liquid chromatography/electrospray ionization tandem mass spectrometry. Rapid Commun. Mass Spectrom. 2007;21:1239\u20131246. doi: 10.1002/rcm.2954.", "ArticleIdList": ["10.1002/rcm.2954", "17330218"]}, {"Citation": "Lin C.-W., Tsai F.-J., Tsai C.-H., Lai C.-C., Wan L., Ho T.-Y., Hsieh C.-C., Chao P.-D.L. Anti-SARS coronavirus 3C-like protease effects of Isatis indigotica root and plant-derived phenolic compounds. Antivir. Res. 2005;68:36\u201342. doi: 10.1016/j.antiviral.2005.07.002.", "ArticleIdList": ["10.1016/j.antiviral.2005.07.002", "PMC7114321", "16115693"]}, {"Citation": "Moloudizargari M., Mikaili P., Aghajanshakeri S., Asghari M.H., Shayegh J. Pharmacological and therapeutic effects of Peganum harmala and its main alkaloids. Pharmacogn. Rev. 2013;7:199. doi: 10.4103/0973-7847.120524.", "ArticleIdList": ["10.4103/0973-7847.120524", "PMC3841998", "24347928"]}, {"Citation": "Serseg T., Benarous K., Yousfi M. Hispidin and Lepidine E: Two Natural Compounds and Folic acid as Potential Inhibitors of 2019-novel coronavirus Main Protease (2019-nCoVMpro), molecular docking and SAR study. arXiv. 20202004.08920", "ArticleIdList": ["32321407"]}, {"Citation": "G\u00fcnayd\u0131n K., Erim F. Determination of khellin and visnagin in Ammi visnaga fruits by capillary electrophoresis. J. Chromatogr. A. 2002;954:291\u2013294. doi: 10.1016/S0021-9673(02)00168-1.", "ArticleIdList": ["10.1016/S0021-9673(02)00168-1", "12058914"]}, {"Citation": "Hudson J., Graham E., Hudson L., Towers G. The mechanism of antiviral phototoxicity of the furanochromones visnagin and khellin. Planta Med. 1988;54:131\u2013135. doi: 10.1055/s-2006-962370.", "ArticleIdList": ["10.1055/s-2006-962370", "3406172"]}, {"Citation": "Chan J., Shultis E., Carr S., DeBrosse C., Eggleston D., Francis T., Hyland L., Johnson W., Killmer L. Novel phloroglucinols from the plant Melicope sessilifloro (Rutaceae) J. Org. Chem. 1989;54:2098\u20132103. doi: 10.1021/jo00270a018.", "ArticleIdList": ["10.1021/jo00270a018"]}, {"Citation": "Nishizawa M., Yamada H., Sano J., It\u00f4 S., Hayashi Y., Ikeda H., Shiro M., Tokuda H. Structure of syzygiol: A skin-tumor promotion inhibitor. Tetrahedron Lett. 1991;32:211\u2013212. doi: 10.1016/0040-4039(91)80857-3.", "ArticleIdList": ["10.1016/0040-4039(91)80857-3"]}, {"Citation": "Tada M., Chiba K., Yoshii T. Natural Products as Antiviral Agents. Springer; Berlin/Heidelberg, Germany: 1992. Antiviral activity of natural phloroglucinols and their analogues; pp. 239\u2013255."}, {"Citation": "Kohmoto S., Mcconnell O.J., Wright A., Cross S. Isospongiadiol, a cytotoxic and antiviral diterpene from a Caribbean deep water marine sponge, Spongia sp. Chem. Lett. 1987;16:1687\u20131690. doi: 10.1246/cl.1987.1687.", "ArticleIdList": ["10.1246/cl.1987.1687"]}, {"Citation": "Lampis G., Deidda D., Maullu C., Madeddu M.A., Pompei R., Delle Monache F., Satta G. Sattabacins and sattazolins: New biologically active compounds with antiviral properties extracted from a Bacillus sp. J. Antibiot. 1995;48:967\u2013972. doi: 10.7164/antibiotics.48.967.", "ArticleIdList": ["10.7164/antibiotics.48.967", "7592064"]}, {"Citation": "Davidson B.S., Schumacher R.W. Isolation and synthesis of caprolactins A and B, new caprolactams from a marine bacterium. Tetrahedron. 1993;49:6569\u20136574. doi: 10.1016/S0040-4020(01)81825-1.", "ArticleIdList": ["10.1016/S0040-4020(01)81825-1"]}, {"Citation": "Nakagawa A., Iwai Y., Hashimoto H., Miyazaki N., Oiwa R., Takahashi Y., Hirano A., Shibukawa N., Kojima Y., Omura S. Virantmycin, a new antiviral antibiotic produced by a strain of Streptomyces. J. Antibiot. 1981;34:1408\u20131415. doi: 10.7164/antibiotics.34.1408.", "ArticleIdList": ["10.7164/antibiotics.34.1408", "7319904"]}, {"Citation": "Omura S., Nakagawa A., Hashimoto H., Oiwa R., Iwai Y., Hirano A., Shibukawa N., Kojima Y. Virantmycin, a potent antiviral antibiotic produced by a strain of Streptomyces. J. Antibiot. 1980;33:1395\u20131396. doi: 10.7164/antibiotics.33.1395.", "ArticleIdList": ["10.7164/antibiotics.33.1395", "7251481"]}, {"Citation": "Xia X., Maliski E.G., Gallant P., Rogers D. Classification of kinase inhibitors using a Bayesian model. J. Med. Chem. 2004;47:4463\u20134470. doi: 10.1021/jm0303195.", "ArticleIdList": ["10.1021/jm0303195", "15317458"]}, {"Citation": "BIOVIA  QSAR, ADMET and Predictive Toxicology.  [(accessed on 20 May 2020)].  Available online:  https://www.3dsbiovia.com/products/collaborative-science/biovia-discovery-studio/qsar-admet-and-predictive-toxicology.html."}, {"Citation": "Subashchandrabose S., Saleem H., Erdogdu Y., Rajarajan G., Thanikachalam V. FT-Raman, FT-IR spectra and total energy distribution of 3-pentyl-2, 6-diphenylpiperidin-4-one: DFT method. Spectrochim. Acta Part A Mol. Biomol. Spectrosc. 2011;82:260\u2013269. doi: 10.1016/j.saa.2011.07.046.", "ArticleIdList": ["10.1016/j.saa.2011.07.046", "21862393"]}, {"Citation": "Bazeera A.Z., Selvaraj S., Mohamed A.S. Spectroscopic analysis (Raman, FT-IR, UV, NMR), HUMO, LUMO and first order hyper polarizability calculations of Nor Leucine Maleate (DLNM) using DFT methods. Wutan Huatan Jisuan Jishu. 2020;16:266\u2013277."}, {"Citation": "Mohammed H.S., Tripathi V.D., Darghouth A.A. Synthesis, Characterization, DFT calculation and Antimicrobial Activity of Co (II) and Cu (II) complexes with azo dye. J. Phys. Conf. Ser. 2019;1294:52051. doi: 10.1088/1742-6596/1294/5/052051.", "ArticleIdList": ["10.1088/1742-6596/1294/5/052051"]}, {"Citation": "Fleming I. Frontier Orbitals and Organic Chemical Reactions. Wiley; Hoboken, NJ, USA: 1977."}, {"Citation": "El-Nahass M., Kamel M., El-Deeb A., Atta A., Huthaily S. Ab initio HF, DFT and experimental (FT-IR) investigation of vibrational spectroscopy of PN, N-dimethylaminobenzylidenemalononitrile (DBM) Spectrochim. Acta Part A Mol. Biomol. Spectrosc. 2011;79:443\u2013450. doi: 10.1016/j.saa.2011.02.055.", "ArticleIdList": ["10.1016/j.saa.2011.02.055", "21514212"]}, {"Citation": "Bitencourt-Ferreira G., de Azevedo Junior W.F. Electrostatic Potential Energy in Protein-Drug Complexes. Curr. Med. Chem. 2021;28:4954\u20134971. doi: 10.2174/0929867328666210201150842.", "ArticleIdList": ["10.2174/0929867328666210201150842", "33593246"]}, {"Citation": "N\u00e1ray-Szab\u00f3 G. Analysis of molecular recognition: Steric electrostatic and hydrophobic complementarity. J. Mol. Recognit. 1993;6:205\u2013210. doi: 10.1002/jmr.300060409.", "ArticleIdList": ["10.1002/jmr.300060409", "7522489"]}, {"Citation": "Matin M.M., Hasan M.S., Uzzaman M., Bhuiyan M.M.H., Kibria S.M., Hossain M.E., Roshid M.H. Synthesis, spectroscopic characterization, molecular docking, and ADMET studies of mannopyranoside esters as antimicrobial agents. J. Mol. Struct. 2020;1222:128821. doi: 10.1016/j.molstruc.2020.128821.", "ArticleIdList": ["10.1016/j.molstruc.2020.128821"]}, {"Citation": "Genheden S., Ryde U. Comparison of end-point continuum-solvation methods for the calculation of protein-ligand binding free energies. Proteins. 2012;80:1326\u20131342. doi: 10.1002/prot.24029.", "ArticleIdList": ["10.1002/prot.24029", "22274991"]}, {"Citation": "Wang E., Sun H., Wang J., Wang Z., Liu H., Zhang J.Z.H., Hou T. End-Point Binding Free Energy Calculation with MM/PBSA and MM/GBSA: Strategies and Applications in Drug Design. Chem. Rev. 2019;119:9478\u20139508. doi: 10.1021/acs.chemrev.9b00055.", "ArticleIdList": ["10.1021/acs.chemrev.9b00055", "31244000"]}, {"Citation": "Elkaeed E.B., Elkady H., Belal A., Alsfouk B.A., Ibrahim T.H., Abdelmoaty M., Arafa R.K., Metwaly A.M., Eissa I.H. Multi-Phase In Silico Discovery of Potential SARS-CoV-2 RNA-Dependent RNA Polymerase Inhibitors among 3009 Clinical and FDA-Approved Related Drugs. Processes. 2022;10:530. doi: 10.3390/pr10030530.", "ArticleIdList": ["10.3390/pr10030530"]}, {"Citation": "Suleimen Y.M., Jose R.A., Suleimen R.N., Ishmuratova M.Y., Toppet S., Dehaen W., Alsfouk A.A., Elkaeed E.B., Eissa I.H., Metwaly A.M. Isolation and In Silico SARS-CoV-2 Main Protease Inhibition Potential of Jusan Coumarin, a New Dicoumarin from Artemisia glauca. Molecules. 2022;27:2281. doi: 10.3390/molecules27072281.", "ArticleIdList": ["10.3390/molecules27072281", "PMC9000794", "35408682"]}, {"Citation": "Eissa I.H., Alesawy M.S., Saleh A.M., Elkaeed E.B., Alsfouk B.A., El-Attar A.-A.M., Metwaly A.M. Ligand and Structure-Based In Silico Determination of the Most Promising SARS-CoV-2 nsp16-nsp10 2\u2032-o-Methyltransferase Complex Inhibitors among 3009 FDA Approved Drugs. Molecules. 2022;27:2287. doi: 10.3390/molecules27072287.", "ArticleIdList": ["10.3390/molecules27072287", "PMC9000629", "35408684"]}, {"Citation": "Ibrahim M.K., Eissa I.H., Abdallah A.E., Metwaly A.M., Radwan M., ElSohly M. Design, synthesis, molecular modeling and anti-hyperglycemic evaluation of novel quinoxaline derivatives as potential PPAR\u03b3 and SUR agonists. Bioorganic Med. Chem. 2017;25:1496\u20131513. doi: 10.1016/j.bmc.2017.01.015.", "ArticleIdList": ["10.1016/j.bmc.2017.01.015", "28117121"]}, {"Citation": "Ibrahim M.K., Eissa I.H., Alesawy M.S., Metwaly A.M., Radwan M.M., ElSohly M.A. Design, synthesis, molecular modeling and anti-hyperglycemic evaluation of quinazolin-4 (3H)-one derivatives as potential PPAR\u03b3 and SUR agonists. Bioorganic Med. Chem. 2017;25:4723\u20134744. doi: 10.1016/j.bmc.2017.07.015.", "ArticleIdList": ["10.1016/j.bmc.2017.07.015", "28720328"]}, {"Citation": "El-Zahabi M.A., Elbendary E.R., Bamanie F.H., Radwan M.F., Ghareib S.A., Eissa I.H. Design, synthesis, molecular modeling and anti-hyperglycemic evaluation of phthalimide-sulfonylurea hybrids as PPAR\u03b3 and SUR agonists. Bioorganic Chem. 2019;91:103115. doi: 10.1016/j.bioorg.2019.103115.", "ArticleIdList": ["10.1016/j.bioorg.2019.103115", "31310882"]}, {"Citation": "Youssef M.I., Zhou Y., Eissa I.H., Wang Y., Zhang J., Jiang L., Hu W., Qi J., Chen Z. Tetradecyl 2, 3-dihydroxybenzoate alleviates oligodendrocyte damage following chronic cerebral hypoperfusion through IGF-1 receptor. Neurochem. Int. 2020;138:104749. doi: 10.1016/j.neuint.2020.104749.", "ArticleIdList": ["10.1016/j.neuint.2020.104749", "32387468"]}, {"Citation": "Hagras M., El Deeb M.A., Elzahabi H.S., Elkaeed E.B., Mehany A.B., Eissa I.H. Discovery of new quinolines as potent colchicine binding site inhibitors: Design, synthesis, docking studies, and anti-proliferative evaluation. J. Enzym. Inhib. Med. Chem. 2021;36:640\u2013658. doi: 10.1080/14756366.2021.1883598.", "ArticleIdList": ["10.1080/14756366.2021.1883598", "PMC7889231", "33588683"]}, {"Citation": "Alsaif N.A., Dahab M.A., Alanazi M.M., Obaidullah A.J., Al-Mehizia A.A., Alanazi M.M., Aldawas S., Mahdy H.A., Elkady H. New quinoxaline derivatives as VEGFR-2 inhibitors with anticancer and apoptotic activity: Design, molecular modeling, and synthesis. Bioorganic Chem. 2021;110:104807. doi: 10.1016/j.bioorg.2021.104807.", "ArticleIdList": ["10.1016/j.bioorg.2021.104807", "33721808"]}, {"Citation": "Eissa I.H., Ibrahim M.K., Metwaly A.M., Belal A., Mehany A.B., Abdelhady A.A., Elhendawy M.A., Radwan M.M., ElSohly M.A., Mahdy H.A. Design, molecular docking, in vitro, and in vivo studies of new quinazolin-4(3H)-ones as VEGFR-2 inhibitors with potential activity against hepatocellular carcinoma. Bioorganic Chem. 2021;107:104532. doi: 10.1016/j.bioorg.2020.104532.", "ArticleIdList": ["10.1016/j.bioorg.2020.104532", "33334586"]}, {"Citation": "Alanazi M.M., Mahdy H.A., Alsaif N.A., Obaidullah A.J., Alkahtani H.M., Al-Mehizia A.A., Alsubaie S.M., Dahab M.A., Eissa I.H. New bis ([1,2,4] triazolo)[4, 3-a:3\u2032,4\u2032-c] quinoxaline derivatives as VEGFR-2 inhibitors and apoptosis inducers: Design, synthesis, in silico studies, and anticancer evaluation. Bioorganic Chem. 2021;112:104949. doi: 10.1016/j.bioorg.2021.104949.", "ArticleIdList": ["10.1016/j.bioorg.2021.104949", "34023640"]}, {"Citation": "Nasser A.A., Eissa I.H., Oun M.R., El-Zahabi M.A., Taghour M.S., Belal A., Saleh A.M., Mehany A.B., Luesch H., Mostafa A.E. Discovery of new pyrimidine-5-carbonitrile derivatives as anticancer agents targeting EGFR WT and EGFR T790M. Org. Biomol. Chem. 2020;18:7608\u20137634. doi: 10.1039/D0OB01557A.", "ArticleIdList": ["10.1039/D0OB01557A", "32959865"]}, {"Citation": "El-Adl K., Ibrahim M.-K., Alesawy M.S., Eissa I.H. [1,2,4] Triazolo [4,3-c] quinazoline and bis ([1,2,4] triazolo)[4,3-a: 4\u2032,3\u2032-c] quinazoline derived DNA intercalators: Design, synthesis, in silico ADMET profile, molecular docking and anti-proliferative evaluation studies. Bioorganic Med. Chem. 2021;30:115958. doi: 10.1016/j.bmc.2020.115958.", "ArticleIdList": ["10.1016/j.bmc.2020.115958", "33360576"]}, {"Citation": "El-Metwally S.A., Abou-El-Regal M.M., Eissa I.H., Mehany A.B., Mahdy H.A., Elkady H., Elwan A., Elkaeed E.B. Discovery of thieno [2, 3-d] pyrimidine-based derivatives as potent VEGFR-2 kinase inhibitors and anti-cancer agents. Bioorganic Chem. 2021;112:104947. doi: 10.1016/j.bioorg.2021.104947.", "ArticleIdList": ["10.1016/j.bioorg.2021.104947", "33964580"]}, {"Citation": "Eissa I.H., Dahab M.A., Ibrahim M.K., Alsaif N.A., Alanazi A., Eissa S.I., Mehany A.B., Beauchemin A.M. Design and discovery of new antiproliferative 1,2,4-triazin-3(2H)-ones as tubulin polymerization inhibitors targeting colchicine binding site. Bioorganic Chem. 2021;112:104965. doi: 10.1016/j.bioorg.2021.104965.", "ArticleIdList": ["10.1016/j.bioorg.2021.104965", "34020238"]}, {"Citation": "Yousef R., Sakr H., Eissa I., Mehany A., Metwaly A., Elhendawy M.A., Radwan M., ElSohly M.A., Abulkhair H.S., El-Adl K. New quinoxaline-2 (1H)-ones as potential VEGFR-2 inhibitors: Design, synthesis, molecular docking, ADMET profile and anti-proliferative evaluations. New J. Chem. 2021;45:16949. doi: 10.1039/D1NJ02509K.", "ArticleIdList": ["10.1039/D1NJ02509K", "34175720"]}, {"Citation": "Amer H.H., Alotaibi S.H., Trawneh A.H., Metwaly A.M., Eissa I.H. Anticancer activity, spectroscopic and molecular docking of some new synthesized sugar hydrazones, Arylidene and \u03b1-Aminophosphonate derivatives. Arab. J. Chem. 2021;14:103348. doi: 10.1016/j.arabjc.2021.103348.", "ArticleIdList": ["10.1016/j.arabjc.2021.103348"]}, {"Citation": "Alesawy M.S., Al-Karmalawy A.A., Elkaeed E.B., Alswah M., Belal A., Taghour M.S., Eissa I.H. Design and discovery of new 1,2,4-triazolo [4,3-c] quinazolines as potential DNA intercalators and topoisomerase II inhibitors. Arch. Der Pharm. 2021;354:2000237. doi: 10.1002/ardp.202000237.", "ArticleIdList": ["10.1002/ardp.202000237", "33226150"]}, {"Citation": "Alanazi M.M., Elkady H., Alsaif N.A., Obaidullah A.J., Alkahtani H.M., Alanazi M.M., Alharbi M.A., Eissa I.H., Dahab M.A. New quinoxaline-based VEGFR-2 inhibitors: Design, synthesis, and antiproliferative evaluation with in silico docking, ADMET, toxicity, and DFT studies. RSC Adv. 2021;11:30315\u201330328. doi: 10.1039/D1RA05925D.", "ArticleIdList": ["10.1039/D1RA05925D", "PMC9044819", "35493991"]}, {"Citation": "Parmar D.R., Soni J.Y., Guduru R., Rayani R.H., Kusurkar R.V., Vala A.G., Talukdar S.N., Eissa I.H., Metwaly A.M., Khalil A. Discovery of new anticancer thiourea-azetidine hybrids: Design, synthesis, in vitro antiproliferative, SAR, in silico molecular docking against VEGFR-2, ADMET, toxicity, and DFT studies. Bioorganic Chem. 2021;115:105206. doi: 10.1016/j.bioorg.2021.105206.", "ArticleIdList": ["10.1016/j.bioorg.2021.105206", "34339975"]}, {"Citation": "Phillips J.C., Braun R., Wang W., Gumbart J., Tajkhorshid E., Villa E., Chipot C., Skeel R.D., Kale L., Schulten K. Scalable molecular dynamics with NAMD. J. Comput. Chem. 2005;26:1781\u20131802. doi: 10.1002/jcc.20289.", "ArticleIdList": ["10.1002/jcc.20289", "PMC2486339", "16222654"]}, {"Citation": "Ribeiro J.V., Bernardi R.C., Rudack T., Stone J.E., Phillips J.C., Freddolino P.L., Schulten K. QwikMD\u2014Integrative Molecular Dynamics Toolkit for Novices and Experts. Sci. Rep. 2016;6:26536. doi: 10.1038/srep26536.", "ArticleIdList": ["10.1038/srep26536", "PMC4877583", "27216779"]}, {"Citation": "Best R.B., Zhu X., Shim J., Lopes P.E., Mittal J., Feig M., Mackerell A.D., Jr. Optimization of the additive CHARMM all-atom protein force field targeting improved sampling of the backbone \u03c6, \u03c8 and side-chain \u03c71 and \u03c72 dihedral angles. J. Chem. Theory Comput. 2012;8:3257\u20133273. doi: 10.1021/ct300400x.", "ArticleIdList": ["10.1021/ct300400x", "PMC3549273", "23341755"]}, {"Citation": "Yu W., He X., Vanommeslaeghe K., MacKerell A.D., Jr. Extension of the CHARMM General Force Field to sulfonyl-containing compounds and its utility in biomolecular simulations. J. Comput. Chem. 2012;33:2451\u20132468. doi: 10.1002/jcc.23067.", "ArticleIdList": ["10.1002/jcc.23067", "PMC3477297", "22821581"]}, {"Citation": "Nos\u00e9 S., Klein M.L. Constant pressure molecular dynamics for molecular systems. Mol. Phys. 1983;50:1055\u20131076. doi: 10.1080/00268978300102851.", "ArticleIdList": ["10.1080/00268978300102851"]}, {"Citation": "Nos\u00e9 S. A molecular dynamics method for simulations in the canonical ensemble. Mol. Phys. 1984;52:255\u2013268. doi: 10.1080/00268978400101201.", "ArticleIdList": ["10.1080/00268978400101201"]}, {"Citation": "Grest G.S., Kremer K. Molecular dynamics simulation for polymers in the presence of a heat bath. Phys. Rev. A Gen. Phys. 1986;33:3628\u20133631. doi: 10.1103/PhysRevA.33.3628.", "ArticleIdList": ["10.1103/PhysRevA.33.3628", "9897103"]}, {"Citation": "Darden T., York D., Pedersen L. Particle mesh Ewald: AnN\u22c5log(N) method for Ewald sums in large systems. J. Chem. Phys. 1993;98:10089\u201310092. doi: 10.1063/1.464397.", "ArticleIdList": ["10.1063/1.464397"]}, {"Citation": "Essmann U., Perera L., Berkowitz M.L., Darden T., Lee H., Pedersen L.G. A smooth particle mesh Ewald method. J. Chem. Phys. 1995;103:8577\u20138593. doi: 10.1063/1.470117.", "ArticleIdList": ["10.1063/1.470117"]}, {"Citation": "Ryckaert J.-P., Ciccotti G., Berendsen H.J.C. Numerical integration of the cartesian equations of motion of a system with constraints: Molecular dynamics of n-alkanes. J. Comput. Phys. 1977;23:327\u2013341. doi: 10.1016/0021-9991(77)90098-5.", "ArticleIdList": ["10.1016/0021-9991(77)90098-5"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "6", "Day": "26"}, {"Year": "2022", "Month": "7", "Day": "25"}, {"Year": "2022", "Month": "7", "Day": "25"}, {"Year": "2022", "Month": "8", "Day": "12", "Hour": "1", "Minute": "12"}, {"Year": "2022", "Month": "8", "Day": "13", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "8", "Day": "16", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "7", "Day": "29"}], "PublicationStatus": "epublish", "ArticleIdList": ["35955547", "PMC9369012", "10.3390/ijms23158407", "ijms23158407"]}}], "PubmedBookArticle": []}